1. Interspecies differences in plasma protein binding of MS-275, a novel histone deacetylase inhibitor

   • Milin R. Acharya
   • Alex Sparreboom
   • William D. Figg

   Original Article 19 July 2005 Pages: 275 - 281

   

2. Phase I and pharmacokinetic study of amrubicin, a synthetic 9-aminoanthracycline, in patients with refractory or relapsed lung cancer

   • Isamu Okamoto
   • Akinobu Hamada
   • Hideyuki Saito

   Original Article 19 July 2005 Pages: 282 - 288

   

3. Quality of life in patients with advanced gastric cancer treated with second-line chemotherapy

   • Se Hoon Park
   • Woon Ki Lee
   • Dong Bok Shin

   Original Article 12 July 2005 Pages: 289 - 294

   

4. Phosphatidylcholine-associated nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit DNA synthesis and the growth of colon cancer cells in vitro

   • Elizabeth J. Dial
   • J. Rand Doyen
   • Lenard M. Lichtenberger

   Original Article 20 July 2005 Pages: 295 - 300

   

5. Differential sensitivity of paclitaxel-induced apoptosis in human esophageal squamous cell carcinoma cell lines

   • Ahmad Faried
   • Leri S. Faried
   • Hiroyuki Kuwano

   Original Article 19 July 2005 Pages: 301 - 308

   

6. A pilot study on the safety of combining chrysin, a non-absorbable inducer of UGT1A1, and irinotecan (CPT-11) to treat metastatic colorectal cancer

   • Peter J. Tobin
   • Philip Beale
   • Stephen Clarke

   Original Article 08 July 2005 Pages: 309 - 316

7. p53-independent G₁ cell cycle arrest of human colon carcinoma cells HT-29 by sulforaphane is associated with induction of p21^CIP1 and inhibition of expression of cyclin D1

   • Guoxiang Shen
   • Changjiang Xu
   • Ah-Ng Tony Kong

   Original Article 17 September 2005 Pages: 317 - 327

   

8. shRNA-targeted hTERT suppress cell proliferation of bladder cancer by inhibiting telomerase activity

   • Lin Zou
   • Penghui Zhang
   • Zhiguang Tu

   Original Article 19 July 2005 Pages: 328 - 334

   

9. Accelerator mass spectrometry allows for cellular quantification of doxorubicin at femtomolar concentrations

   • M. W. DeGregorio
   • K. H. Dingley
   • K. W. Turteltaub

   Original Article 27 July 2005 Pages: 335 - 342

   

10. Imaging the pharmacokinetics of [F-18]FAU in patients with tumors: PET studies

    • Haihao Sun
    • Jerry M. Collins
    • Anthony F. Shields

    Original Article 07 July 2005 Pages: 343 - 348

    

11. Chloroacetaldehyde: mode of antitumor action of the ifosfamide metabolite

    • Svenja K. Brüggemann
    • Kerstin Radike
    • Thomas Wagner

    Original Article 25 August 2005 Pages: 349 - 356

    

12. Bcl-2-mediated potentiation of neocarzinostatin-induced apoptosis: requirement for caspase-3, sulfhydryl groups, and cleavable Bcl-2

    • Zhiping Mi
    • Borah Hong
    • Nina Felice Schor

    Original Article 05 July 2005 Pages: 357 - 367

    

13. Administration sequence-dependent antitumor effects of paclitaxel and 5-fluorouracil in the human gastric cancer cell line MKN45

    • Yuji Toiyama
    • Koji Tanaka
    • Masato Kusunoki

    Original Article 02 August 2005 Pages: 368 - 375

    

14. Curcuminoids purified from turmeric powder modulate the function of human multidrug resistance protein 1 (ABCC1)

    • Wanida Chearwae
    • Chung-Pu Wu
    • Pornngarm Limtrakul

    Original Article 14 July 2005 Pages: 376 - 388

    

15. Role of mitochondria and mitochondrial cytochrome c in tubeimoside I-mediated apoptosis of human cervical carcinoma HeLa cell line

    • Fang Wang
    • Rundi Ma
    • Lijian Yu

    Original Article 20 September 2005 Pages: 389 - 399